Caxton Associates (UK)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Caxton Associates (UK)'s JNJ Position: Q2 2026 in Review
Caxton Associates (UK) opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 2,780 shares worth $706K. The stake represents 0.01% of the portfolio and ranks #476 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in JNJ as recently as Q4 2025.
Caxton Associates (UK) first reported a position in JNJ in Q2 2025 and has held it in 4 quarters since. The position peaked at $715K in Q3 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Caxton Associates (UK) held 2,780 shares of Johnson & Johnson worth $706K as of Q2 2026.
- Johnson & Johnson was a new Caxton Associates (UK) position in Q2 2026.
- Johnson & Johnson made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #476 holding.
- Caxton Associates (UK) first reported a position in Johnson & Johnson in Q2 2025 and has held it in 4 quarters since.
- Caxton Associates (UK)'s Johnson & Johnson position peaked at $715K in Q3 2025.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.